drugset / Trial / NCT02033369

Summary

This study aims to determine whether ventral striatal dopamine release is a mechanism of reward motivation in major depression, whether dopamine release is low in depression, and whether DA release and reward motivation predict response to dopamine-targeted treatment with pramipexole.

Timeline

Start
2014-02
Primary completion
2016-12
Completion
2017-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pramipexole Unknown 2.5 mg Oral